NDAINHALATIONPOWDER
Approved
Oct 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
ARIDOL KIT (mannitol) by Otsuka is 12. Approved for cystic fibrosis. First approved in 2010.
Drug data last refreshed 20h ago
Mechanism of Action
12.1 Mechanism of Action The precise mechanisms through which inhaled mannitol causes bronchoconstriction are not known. 12.2 Pharmacodynamics The response to inhaled mannitol is reported as the delivered dose of mannitol causing a 15% reduction in FEV 1 and is expressed as PD 15 . 12.3…
Worked on ARIDOL KIT at Otsuka? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.